Global Innovative Health Industries Alliance
The Global Innovative Health Industries Alliance is a collaborative platform for international associations representing biopharmaceuticals, biotech, diagnostics, medical devices, and diagnostic imaging industries to encourage dialogue and collaboration for innovation.
Overview
The Global Innovative Health Industries Alliance brings together the innovative health industries to encourage dialogue and collaboration for innovation and access.
The Alliance was founded by IFPMA, the International Council of Biotechnology Associations, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association, and the Global Self-Care Federation.
Depending on the issue, the group is also joined by ad-hoc members such as Global Medical Technology Alliance.
Key focus areas
Establishes
a platform for the exchange of information of mutual interest.
Promotes
a holistic approach to access and affordability, pandemic awareness and supports global health security as well as patient safety and ethical conduct by healthcare professionals.
Advocates
for the value of innovation through a supportive and sustainable ecosystem for innovative health industries, regulatory systems, scientific research, and business ethics.
Innonvation
Meeting the highly ambitious targets of the Sustainable Development Goals (SDGs) by 2030 and responding adequately to global health crises such as the COVID-19 pandemic will require further scientific breakthroughs and strategic innovations.
Innovative health industries have a fundamental role to play in driving innovation and in contributing to the health ecosystem of which they are a part.
The Alliance is committed to delivering high-quality healthcare to people worldwide as well as safeguarding innovation and promoting access to innovation.
Get in touch
If you’re pursuing similar objectives to the Alliance and would like to discuss our work, please use the form on our contact page to get in touch with Grega Kumer, Associate Director, Government Relations at IFPMA. Mark your message for Grega’s attention.
Other partnerships and alliances
See all
INTREPID Alliance
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Navigating Innovation & Research Opportunities (NIRO)
Helping actors in research and innovation identify opportunities within and beyond the European Union
BeCOME
BeCOME (Beyond COVID Monitoring Excellence) was initiated to create a sustainable forum where experts in pharmacovigilance and pharmacoepidemiology from industry, public health, regulators, and academia can collectively meet.